Search for: "TARGETED MEDICAL PHARMA, INC." Results 61 - 76 of 76
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’ still… [read post]
29 Aug 2008, 1:25 pm
: (IP finance), Facebook removes international access to Scrabulous, except from India: (Ars Technica), (Techdirt), Reverse engineering can resolve conflict between standardisation and competition: (Techdirt), Benefits of piracy aren’t always in the expected places: (Techdirt)   Events 1-3 September: Federation of Indian Chambers of Commerce and Industry, Department of Industrial Property and Promotion, and WIPO conference on ‘Development and IP: Building synergies… [read post]
Improper Patient Referrals Nature of the problem: The government and whistleblowers continue to target pharmacies, including specialty pharmacies, for improper referrals in violation of the federal AKS, which prohibits the provision of anything of value to healthcare providers in exchange for referrals of items or services that may be reimbursed by federal healthcare programs. [read post]
23 May 2008, 1:03 am
– Brdo: (IPR-Helpdesk), 5-6 June: USFDA public meeting on evaluation of product trade names: (FDA Law Blog), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 16 June / 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ -… [read post]
15 Dec 2018, 7:41 am by Cynthia Marcotte Stamer
Stamer’s clients include employers and other workforce management organizations; employer, union, association, government and other insured and self-insured health and other employee benefit plan sponsors, benefit plans, fiduciaries, administrators, and other plan vendors;  managed care organizations, insurers, self-insured health plans and other payers and their management; public and private, domestic and international hospitals, health care systems, clinics, skilled nursing,… [read post]
17 Nov 2018, 12:10 pm by Schachtman
Despite reports of an odd journal here or there “abolishing” p-values, most medical journals continue to require the presentation of either p-values or confidence intervals. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ… [read post]
13 Jul 2021, 10:58 am by Simon Lester
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]
30 May 2012, 1:37 pm by Peter Rost
This includes plans to target responsible executives — not just companies — by toughening the CIAs to require management and a board committee to certify company compliance.Read more in Time Magazine. [read post]
15 Feb 2012, 7:42 am by Peter Rost
This includes plans to target responsible executives — not just companies — by toughening the CIAs to require management and a board committee to certify company compliance.Read more in Time Magazine. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
This includes plans to target responsible executives — not just companies — by toughening the CIAs to require management and a board committee to certify company compliance.Read more in Time Magazine. [read post]
9 Sep 2011, 8:40 am by Peter Rost
This includes plans to target responsible executives — not just companies — by toughening the CIAs to require management and a board committee to certify company compliance.Read more in Time Magazine. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
This includes plans to target responsible executives — not just companies — by toughening the CIAs to require management and a board committee to certify company compliance.Read more in Time Magazine. [read post]
11 Feb 2011, 7:51 am by Peter Rost
This includes plans to target responsible executives — not just companies — by toughening the CIAs to require management and a board committee to certify company compliance.Read more in Time Magazine. [read post]
2 Oct 2010, 8:43 am by Peter Rost
This includes plans to target responsible executives — not just companies — by toughening the CIAs to require management and a board committee to certify company compliance.Read more in Time Magazine. [read post]